Pharmaceuticals

Global Pharma Grade Calcium Sulphate Market Forecast 2026–2035: Long-Term Growth Insights

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma grade calcium sulphate market from 2026–2035 with trusted insights from The Business Research Company

How much is the Pharma Grade Calcium Sulphate Market valued at in 2026, and what valuation is forecast for 2030?

The pharma grade calcium sulphate market size has seen significant growth in recent years. This market is set to expand from $0.96 billion in 2025 to $1.04 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.5%. The historical growth can be attributed to several factors, including the expansion in pharmaceutical manufacturing, increased demand for solid dosage forms, the growth of generic drug production, rising utilization of calcium-based excipients, and a strong regulatory focus on excipient quality.

The market for pharma grade calcium sulphate is projected to experience substantial expansion in the coming years, reaching $1.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion throughout the forecast period stems from factors such as an increase in global drug production, the growing application of high-performance excipients, a heightened need for uniform formulation quality, the enlargement of nutraceutical manufacturing, and innovations in excipient processing. Significant trends anticipated during this period encompass a surging requirement for high-purity pharmaceutical excipients, their increasing integration into tablet and capsule formulations, greater uptake in the production of calcium supplements, the broadening of quality-controlled excipient manufacturing, and an intensified emphasis on materials that comply with regulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Drivers Are Influencing The Growth Of The Pharma Grade Calcium Sulphate Market?

The increasing need for pharmaceuticals is anticipated to drive the expansion of the pharma grade calcium sulphate market in the future. Pharmaceuticals are defined as drugs and medicines created, produced, and utilized for the diagnosis, treatment, or prevention of illnesses in both humans and animals. This rising demand for pharmaceuticals primarily stems from the increasing occurrence of chronic illnesses, leading more people to need ongoing medications for managing conditions like diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate improves pharmaceutical formulations by acting as a high-purity excipient, which guarantees uniform tablet hardness, stability, and the regulated release of active components. For example, in April 2024, Eurostat, the official statistical agency of the European Union located in Luxembourg, reported that imports of medicinal and pharmaceutical products into the EU rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Concurrently, EU exports amounted to $319.2 billion (€277 billion), creating a trade surplus of $182.0 billion (€158 billion). Consequently, the increasing need for pharmaceuticals is fueling the expansion of the pharma grade calcium sulphate market.

What Segments Are Included Within The Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Which Trends Are Guiding The Evolution Of The Pharma Grade Calcium Sulphate Market?

Leading companies within the pharma grade calcium sulphate market are concentrating their efforts on creating innovative products, specifically through the application of synthetic medical-grade bassanite, to elevate the purity and consistency of calcium sulphate offerings. Synthetic medical-grade bassanite, which is a high-purity and partially dehydrated form of calcium sulphate (CaSO₄·0.5H₂O), plays a crucial role in manufacturing pharma-grade calcium sulphate by supplying a consistent and contaminant-free material that adheres to stringent regulatory requirements for medical and pharmaceutical uses. For instance, in February 2025, the Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx. These innovative drug-eluting bone graft products were developed utilizing synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement composed of calcium sulfate hemihydrate enhanced with phosphate ions, making it ideal for filling bone defects and delivering drugs at the implantation site for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, facilitating sustained drug release for more than 30 days. These advancements signify a considerable progression in localized therapy for bone infections and regeneration, illustrating the potential of pharma-grade calcium sulfate in developing next-generation biomedical solutions that comply with rigorous international standards.

Who Are The Major Companies Operating In The Pharma Grade Calcium Sulphate Market?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharma Grade Calcium Sulphate Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795